Payer PolicyActive
SURG.00100 Cryoablation for Plantar Fasciitis and Plantar Fibroma
ANTHEM-SURG.00100
Anthem
Effective: January 30, 2025
Updated: December 30, 2025
Policy Summary
- Service addressed: Cryoablation (including cryosurgery/neuroablation) for treatment of plantar fasciitis and plantar fibroma. - Coverage: Considered investigational/experimental and not medically necessary; therefore, not covered for these conditions. - Limitations: No covered indications or exceptions are specified; the non-coverage applies to all uses of cryoablation for plantar fasciitis or plantar fibroma.
Coverage Criteria Preview
Key requirements from the full policy
"Use of cryoablation (for example, cryosurgery, neuroablation) for the treatment of either plantar fasciitis or plantar fibroma is consideredinvestigational and not medically necessary."
Sign up to see full coverage criteria, indications, and limitations.